Developing nanomaterials for selective drug delivery in cancer therapy

Dr. Evan Scott, Northwestern University, talks about his research in controlled drug delivery using nanomaterials. His lab aims to develop nanomaterials as drug carriers and understand how they interact with the body. Here, Scott discusses his recent work on selective targeting in the tumor microenvironment, including his published paper on nanotechnology. How Scott is developing newer nanoparticle platforms and a startup company for cancer gene therapy is also discussed.

This video was filmed at AACR 2023.